Michael Tatley

Professor Michael Tatley is a Public Health Physician with a 24-year career in Pharmacovigilance as Director and Medical Assessor in the New Zealand Pharmacovigilance Centre (NZPhvC), the National Adverse Drug Reaction Monitoring

centre – operated by the University of Otago since 1965 on contract to Medsafe, the NZ Ministry of Health drug regulator. His earlier career was in applied Public Health as Director of Metropolitan Health Services for Cape Town, South Africa.

As Director NZPhvC, he established complementary monitoring programs including: the close to real-time safety monitoring of the MeNZB vaccine (a tailor-made vaccine for NZ for a meningococcal B epidemic), Medication Error monitoring, Recreational substance adverse event monitoring, Vaping adverse event monitoring, and a parallel programme to assess COVID vaccine adverse events.

Professor Tatley has served on national policy and advisory committees, Scientific advisory committees and provided Medicines and Vaccines safety case review requests. Internationally, has served on WHO advisory committees and Technical Advisor roles – particularly in the Western Pacific Region and Pacific Islands sub-region.

Aligning with his public health background he has a special interest in Health System Strengthening in Low and Middle-Income Countries. Academically, Professor Tatley has been active in research including supervision of MSc and PhD students.